Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.6 USD | +10.49% | +17.10% | +94.01% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 484M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -76M | EV / Sales 2024 * | - |
Net cash position 2024 * | 327M | Net cash position 2025 * | 501M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-10.5
x | Employees | 91 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.22% |
Latest transcript on Neurogene Inc.
1 day | +10.49% | ||
1 week | +17.10% | ||
1 month | +9.05% | ||
3 months | +21.02% | ||
Current year | +94.01% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 37.6 | +10.49% | 138,019 |
24-05-30 | 34.03 | +2.07% | 56,149 |
24-05-29 | 33.34 | +5.14% | 53,790 |
24-05-28 | 31.71 | -1.25% | 72,000 |
24-05-24 | 32.11 | +1.97% | 48,817 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+94.01% | 484M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- NGNE Stock